Prospect Biosystems, Inc., is a technology-driven proteomics company focused on providing innovative biomarker discovery platforms to accelerate drug discovery, development and commercialization.

Founded in January, 2006, Prospect's customers are engaged in analytical proteomics, biomarker discovery, clinical diagnostics and surgical pathology.

The Company currently occupies laboratory and office space within the NJIT Enterprise Development Center III, 211 Warren Street, Newark, NJ.